NextCure Statistics
Total Valuation
NextCure has a market cap or net worth of $12.26 million. The enterprise value is -$37.73 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NextCure has 28.05 million shares outstanding. The number of shares has increased by 0.44% in one year.
| Current Share Class | 28.05M |
| Shares Outstanding | 28.05M |
| Shares Change (YoY) | +0.44% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 30.73% |
| Float | 20.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.26, with a Debt / Equity ratio of 0.10.
| Current Ratio | 10.26 |
| Quick Ratio | 9.78 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.94% and return on invested capital (ROIC) is -39.67%.
| Return on Equity (ROE) | -63.94% |
| Return on Assets (ROA) | -36.39% |
| Return on Invested Capital (ROIC) | -39.67% |
| Return on Capital Employed (ROCE) | -86.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.15M |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.67% in the last 52 weeks. The beta is 1.04, so NextCure's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -73.67% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 49.78 |
| Average Volume (20 Days) | 173,807 |
Short Selling Information
The latest short interest is 182,944, so 0.65% of the outstanding shares have been sold short.
| Short Interest | 182,944 |
| Short Previous Month | 35,771 |
| Short % of Shares Out | 0.65% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.07M |
| Pretax Income | -61.28M |
| Net Income | -49.52M |
| EBITDA | -50.34M |
| EBIT | -53.07M |
| Earnings Per Share (EPS) | -$1.77 |
Full Income StatementBalance Sheet
The company has $55.86 million in cash and $5.84 million in debt, giving a net cash position of $50.02 million or $1.78 per share.
| Cash & Cash Equivalents | 55.86M |
| Total Debt | 5.84M |
| Net Cash | 50.02M |
| Net Cash Per Share | $1.78 |
| Equity (Book Value) | 55.86M |
| Book Value Per Share | 1.99 |
| Working Capital | 53.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.19 million and capital expenditures -$437,000, giving a free cash flow of -$41.63 million.
| Operating Cash Flow | -41.19M |
| Capital Expenditures | -437,000 |
| Free Cash Flow | -41.63M |
| FCF Per Share | -$1.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |